Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway (vol 560, 216142, 2023)
机构：[1]China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing 100700, Peoples R China[2]Ningxia Med Univ, Sch Basic Med Sci, Yinchuan 750004, Ningxia, Peoples R China[3]East China Normal Univ, Inst Biomed Sci, Shanghai Frontiers Sci Ctr Genome Editing & Cell T, Sch Life Sci,Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China[4]Guangdong Prov Hosp Chinese Med, Breast Dept, Guangzhou 510120, Peoples R China广东省中医院[5]Ningxia Med Univ, Key Lab Fertil Maintenance, Minist Educ, Yinchuan 750004, Ningxia, Peoples R China
第一作者机构：[1]China Acad Chinese Med Sci, Natl Resource Ctr Chinese Mat Med, Beijing 100700, Peoples R China[4]Guangdong Prov Hosp Chinese Med, Breast Dept, Guangzhou 510120, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Zhang Yuzhu,Chen Jing,Mi Dazhao,et al.Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway (vol 560, 216142, 2023)[J].CANCER LETTERS.2023,567:doi:10.1016/j.canlet.2023.216195.
APA：
Zhang, Yuzhu,Chen, Jing,Mi, Dazhao,Ling, Jun,Li, Huachao...&Huang, Luqi.(2023).Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway (vol 560, 216142, 2023).CANCER LETTERS,567,
MLA：
Zhang, Yuzhu,et al."Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway (vol 560, 216142, 2023)".CANCER LETTERS 567.(2023)
医学